Plasma nociceptin/orphanin FQ levels are lower in patients with chronic ischemic cardiovascular diseases--A pilot study
| Autor: | Béla Merkely, Péter Sótonyi, Zoltán Szeberin, István Hartyánszky, György Acsády, Csaba Csobay-Novák, Ferenc Horkay, Kornélia Tekes, Miklós Krepuska, Nóra Szilágyi, Endre Zima |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Male
medicine.medical_specialty Physiology Clinical Biochemistry Down-Regulation Pilot Projects Disease Biochemistry Angina Pectoris Cellular and Molecular Neuroscience Peripheral Arterial Disease Endocrinology Internal medicine medicine Humans Exertion Cause of death Aged Gangrene business.industry Canadian Cardiovascular Society Middle Aged medicine.disease Intermittent claudication Nociceptin receptor Opioid Peptides Aortic valve stenosis Anesthesia Linear Models Female medicine.symptom business |
| Zdroj: | Regulatory peptides. 169(1-3) |
| ISSN: | 1873-1686 |
| Popis: | Clinical studies are limited regarding the role of human nociceptin/orphanin FQ (N/OFQ) in ischemic cardiovascular diseases, which are still the number one cause of death in the developed world. The aim of our study was to measure the plasma levels of N/OFQ in patients with chronic ischemic cardiovascular diseases in a pilot study.Our study population consisted of 22 patients presenting symptoms of stable angina pectoris (SAP): 12 severe Canadian Cardiovascular Society (CCS) III-IV functional class, and 10 with milder SAP (CCS II-III). 12 patients were also enrolled with chronic peripheral artery disease (9 with intermittent claudication; 3 with rest pain and gangrene). Patients were asked to avoid any exertion or given analgetics for their rest pain. Patients had no episodes of chest or limb pain in 1week before their fasting blood samples were taken and N/OFQ plasma levels were measured by radioimmunoassay. 14 healthy subjects without any cardiac risk factors served as a control group.N/OFQ levels were significantly lower in patient groups with severe vs. milder chronic angina (p0.05) and vs. control subjects (p0.01). Patients suffering from peripheral artery disease had also a lower plasma N/OFQ levels than in healthy controls (p0.01). Our findings show that chronic ischemic conditions of atherosclerotic origin are associated with significantly lower plasma N/OFQ levels. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect